C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2002
10/03/2002	WO2002077212A2 D-carbamoylase from arthrobacter crystallopoietes dsm 20117
10/03/2002	WO2002077211A2 A virus (cryptovirus) within the rubulavirus genus and uses therefor
10/03/2002	WO2002077210A2 Methods to culture circovirus
10/03/2002	WO2002077209A1 Transgenic plants with resistance against tobacco rattle virus and corresponding nucleotide sequence
10/03/2002	WO2002077208A1 Antigen-dependent reduction of specific immune reactions by influencing the co-stimulation
10/03/2002	WO2002077207A1 Cell-based assays for the simultaneous and discrete analysis of multiple analytes
10/03/2002	WO2002077206A1 Compositiona and methods useful for hcv infection
10/03/2002	WO2002077205A2 Culture medium for enhanced heterologous protein expression
10/03/2002	WO2002077204A2 Stem cell differentiation
10/03/2002	WO2002077202A1 Culture medium for cell growth and transfection
10/03/2002	WO2002077200A2 Efficient methods for isolating functional g-protein coupled receptors and identifying active effectors and efficient methods to isolate proteins involved in olfaction and efficient methods to isolate and identifying active effectors
10/03/2002	WO2002077179A2 Leinamycin biosynthesis gene cluster and its components and their uses
10/03/2002	WO2002077174A2 Human cytokine receptor
10/03/2002	WO2002077159A2 End group activated polymers with oligonucleotide ligands
10/03/2002	WO2002077155A2 Keratinocyte growth factor-2
10/03/2002	WO2002077036A2 Recombinant production of polyanionic polymers, and uses thereof
10/03/2002	WO2002077029A2 Cd19-specific redirected immune cells
10/03/2002	WO2002077028A1 Polypeptides and nucleic acids for bolekine
10/03/2002	WO2002077027A1 Human stra6-like protein and nucleic acids encoding the same
10/03/2002	WO2002077024A1 Shellfish protein
10/03/2002	WO2002077023A2 A new essential downstream component of the wingless signalling pathway
10/03/2002	WO2002077012A2 Human papilloma virus immunoreative peptides
10/03/2002	WO2002077011A2 Oxidation-reduction sensitive green fluorescent protein variants
10/03/2002	WO2002076578A1 Control of glycoforms in igg
10/03/2002	WO2002076507A2 Uses of opg ligand to modulate immune responses
10/03/2002	WO2002076503A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate
10/03/2002	WO2002076501A2 Blood cell production via activation of the hemoglobin scavenger receptor
10/03/2002	WO2002076486A2 Histidine-rich glycoprotein
10/03/2002	WO2002076386A2 Method of inducing proliferation of retinal stem cells
10/03/2002	WO2002076383A2 Securin is required for chromosomal stability in human cells
10/03/2002	WO2002076337A2 Xenograft bone matrix for orthopedic applications
10/03/2002	WO2002076288A2 Biodegradable, electrically conductiong polymer for tissue engineering applications
10/03/2002	WO2002076285A2 Composition and methods fro the production of biological tissues and tissue constructs
10/03/2002	WO2002076206A2 Methods and compositions for cryopreservation of dissociated primary animal cells
10/03/2002	WO2002076196A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002	WO2002062297A3 Methods and compositions for modulating gluconeogenesis using pgc-1
10/03/2002	WO2002059153A3 Anticoagulants and their uses
10/03/2002	WO2002057424A3 Nucleic acid delivery formulations
10/03/2002	WO2002055109A3 Generation and/or reduction of new lung tissue in an affected lung, by modulation of the wnt-pathway
10/03/2002	WO2002044206A3 Membrane fusion proteins derived from reovirus
10/03/2002	WO2002033057A3 Cytochrome p450 monooxygenases consisting of thermophilic bacteria
10/03/2002	WO2002029086A3 Nucleic acid sequences differentially expressed in cancer tissue
10/03/2002	WO2002029068A3 Virus-based amplification vector for plants
10/03/2002	WO2002024907A3 G-protein coupled receptor hfrbn63
10/03/2002	WO2002020729A3 In vitro human angiogenesis model
10/03/2002	WO2002018611A3 Method for the improved production and isolation of trans-dihydroxycyclohexadiene carboxylic acids and/or derivatives thereof and a genetically modified organism suitable for the above
10/03/2002	WO2002018407A3 Antisense oligonucleotides against vanilloid receptor 1
10/03/2002	WO2002014494A3 Use of a transgene encoding a vertebrate phytase to increase capacity to utilize phytic acid in livestock feed
10/03/2002	WO2002002751A3 Alteration of cell membrane
10/03/2002	WO2001096388A3 Compositions and methods for the therapy and diagnosis of colon cancer
10/03/2002	WO2001079465A3 Nucleic acids encoding polypeptides having haloperoxidase activity
10/03/2002	WO2001071004A3 Proteases
10/03/2002	WO2001021812A9 Phosphatases which activate map kinase pathways
10/03/2002	WO2001020015A9 Reverse transfection method
10/03/2002	WO2001019800A9 Mediators of hedgehog signaling pathways, compositions and uses related thereto
10/03/2002	WO2000069896A9 Molecular interactions in haematopoietic cells
10/03/2002	WO1999064459A3 Gene encoding organic anion transporter
10/03/2002	US20020144310 Isolated polynucleotides and polypeptides relating to loci underlying resistance to soybean cyst nematode and soybean sudden death syndrome and methods employing same
10/03/2002	US20020144308 Viral amplification of recombinant messenger RNA in transgenic plants
10/03/2002	US20020144306 Nucleotide sequences coding polypeptide for use in the generation of disease resistant plants
10/03/2002	US20020144305 Methods and compositions to reduce or eliminate transmission of a transgene
10/03/2002	US20020144299 Nuceotide sequences coding malarial surface protein for use in the treatment and prevention of malaria
10/03/2002	US20020143161 Members of the d52 gene family
10/03/2002	US20020143159 Bone morphogenetic protein (bmp)-17 and bmp-18 compositions
10/03/2002	US20020143150 Monoclonal antibody to the clonotypic structure of a T-cell receptor, a pharmaceutical composition and a diagnostic reagent comprising the same
10/03/2002	US20020142988 G-coupled receptor showing selective affinity for ATP
10/03/2002	US20020142986 Used in the diagnosis or prognosis of liver associated disorders
10/03/2002	US20020142980 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
10/03/2002	US20020142974 Immune activation by double-stranded polynucleotides
10/03/2002	US20020142961 As pharmaceuticals, diagnostics, biosensors and bioreactors
10/03/2002	US20020142959 As drugs, diagnostics, biosensors and bioreactors
10/03/2002	US20020142958 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/03/2002	US20020142467 Method for culturing recombinant cells
10/03/2002	US20020142465 Processing cell or viable tissue; obtain cell or viable tissue, expose to radiation from laser, monitor preferential activity in cell
10/03/2002	US20020142463 Method for the mass propagation of adventitious roots of ginseng, camphor ginseng and wild ginseng by tissue culture and the improvement of their saponin content
10/03/2002	US20020142462 Culture for use in the treatment of cancer, anemia, immunological and autoimmune diseases
10/03/2002	US20020142461 T1 Receptor-like ligand II and uses thereof
10/03/2002	US20020142460 Nervous system cells for use as model in the treatment of nervous system disorders
10/03/2002	US20020142459 Generating vascularized tissue; obtain tissue culture, mix microvessel segment, inject tissue with vascularized graft, evaluate tissue for vascularizat ion
10/03/2002	US20020142458 Prevascularized constructs for implantation to provide blood perfusion
10/03/2002	US20020142457 Cell having the potentiality of differentiation into cardiomyocytes
10/03/2002	US20020142456 Protein for use in the treatment of body weight defects
10/03/2002	US20020142455 Enhanced replication of HCV RNA
10/03/2002	US20020142451 Generation of nodulation inoculant; obtain nutrient broth, mix with iron, monitor cell density factor, evaluate nodulation in propagating plants
10/03/2002	US20020142449 Compositions and methods useful for HCV infection
10/03/2002	US20020142448 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer
10/03/2002	US20020142447 DNA encoding the human serine protease EOS
10/03/2002	US20020142446 DNA encoding the human serine protease EOS
10/03/2002	US20020142444 AL-2 neurotrophic factor
10/03/2002	US20020142436 Enzymatic protein for use in the treatment of tumors, nervous system, cardiovascular, psychological, pregnancy, bone, kidney, respiratory and alimentary canal disorders
10/03/2002	US20020142432 Human endosulfine gene
10/03/2002	US20020142430 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis
10/03/2002	US20020142429 Elongation factor-2 kinase (EF-2 kinase) and methods of use therefor
10/03/2002	US20020142419 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of bone disorders and arthritis
10/03/2002	US20020142401 Isolated gene for methylmalonyl CoA epimerase and uses thereof
10/03/2002	US20020142397 Genetically engineering cell; obtain cell, incubate with cell growth factor, remove nucleus or chromatin, insert into cell, propagate cell
10/03/2002	US20020142392 Human melanocyte stimulating hormone receptor polypeptide and DNA
10/03/2002	US20020142378 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/03/2002	US20020142376 Peptide for use in the diagnosis and treatment of nervous system disorders
10/03/2002	US20020142375 Nucleotide sequences coding G protein coupled receptors for use in the diagnosis and treatment of cancer, adult respiratory distress, nervous system disorders and arthritis

1 ... 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 ... 1827